@TAMU_IBT

Texas A&M Institute of Biosciences & Technology conducts world-class research and trains the next generation of health care professionals.

 Houston, TX
ibt.tamu.edu
Joined October 2013
  • Tweets298
  • Following215
  • Followers285
167Media
MeRT, a PTSD treatment guided by each patient's own EEG, is FDA cleared. Dr. Kenneth Ramos led the trial with Wave Neuroscience, including military participants. ibt.tamu.edu/stories/wave-ne…
Portrait of Dr. Kenneth S. Ramos smiling, wearing a navy suit, light blue shirt and a striped gold, black and silver tie against a dark gray background.

ALT Portrait of Dr. Kenneth S. Ramos smiling, wearing a navy suit, light blue shirt and a striped gold, black and silver tie against a dark gray background.

1
1
23
A "jumping gene" in a blood sample may help profile lung cancer. Dr. Abeer Hassanin in Dr. Kenneth Ramos's lab found exosomal LINE-1 tracked stage, tumor size and smoking history. ibt.tamu.edu/stories/abeer-h…
Maroon graphic with the headline "Lung cancer clues in a blood sample" above a photo of a gloved hand holding a capped tube of blood beside a test tube being filled by a pipette. Text at the bottom reads Texas A&M Health Institute of Biosciences and Technology.

ALT Maroon graphic with the headline "Lung cancer clues in a blood sample" above a photo of a gloved hand holding a capped tube of blood beside a test tube being filled by a pipette. Text at the bottom reads Texas A&M Health Institute of Biosciences and Technology.

16
AACR Cancer Discovery cites Dr. Yubin Zhou (Texas A&M Health Institute of Biosciences and Technology) in a Nobel-week feature on optogenetics' reach into cancer, including light-controlled CAR T work (Nat Nanotechnol 2021). ibt.tamu.edu/stories/yubin-z…
Headshot of Dr. Yubin Zhou, MD, PhD, professor and director of the Center for Translational Cancer Research at the Texas A&M Health Institute of Biosciences and Technology in Houston.

ALT Headshot of Dr. Yubin Zhou, MD, PhD, professor and director of the Center for Translational Cancer Research at the Texas A&M Health Institute of Biosciences and Technology in Houston.

1
37
Dr. Yubin Zhou at Texas A&M Health’s Institute of Biosciences and Technology on Heliox: caffeine-activated tools to control engineered cells and gene-editing systems for safer, more controllable therapies. ibt.tamu.edu/stories/yubin-z…
36
IBT researchers, led by Dr. Suzanne Tomlinson-Mathis, are featured in Drug Discovery Today on Texas’ IDDD Core Network: 750+ projects, 60+ startups, and a statewide model for academic drug discovery. ibt.tamu.edu/stories/ibt-dru…
21
Houston or Bryan: join a one-visit Alzheimer’s study at Texas A&M Health IBT (ages 60–85). ibt.tamu.edu/alzheimers/alzh… · 713-677-7428 · STUDY2026-0045
22
One visit at Texas A&M Health IBT: consent, questions, memory tests, small blood sample. Ages 60–85. Voluntary. ibt.tamu.edu/alzheimers/alzh… · STUDY2026-0045
21
Texas A&M Health IBT is inviting adults 60–85 to a one-visit Alzheimer’s research study (memory tests + small blood sample). Voluntary. No cost. Details: ibt.tamu.edu/alzheimers/alzh… 713-677-7428 · STUDY2026-0045
1
29
Dr. Thomas A. Kent of Texas A&M Health’s IBT has been named to the 2026 Texas Super Doctors list and reports Legacy Hall of Fame status after 15 consecutive years—a physician-scientist in Houston’s Texas Medical Center. ibt.tamu.edu/stories/thomas-…
30
NPAW highlights Dr. Andrés D. Chamorro Parejo (Ramos lab) at Texas A&M Health’s IBT—bioinformatics, precision medicine, chromatin/epigenetics, and single-cell RNA-seq research on lung cancer. ibt.tamu.edu/stories/andres-… #NPAW2026 #PostdocAppreciationWeek #TexasAM
2
88
NPAW at Texas A&M Health introduces PDA co-presidents Dr. Andrés D. Chamorro Parejo and Dr. Vicente Rubio, continuing Chetna Dureja and Rudra Banerjee’s leadership. ibt.tamu.edu/stories/ibt-pda… #NPAW2026 #TexasAM
2
59
IBT investigators, with Wave Neuroscience, led the trial supporting FDA clearance of MeRT for PTSD. PI: Dr. Kenneth S. Ramos, executive director of the Institute of Biosciences and Technology. ibt.tamu.edu/stories/wave-ne…
24
NVIDIA’s new case study on Texas A&M University’s VISION supercomputer features Dr. Reid T. Powell at IBT in Houston: 10.4 million molecular simulations in about a week for computational drug discovery. ibt.tamu.edu/stories/reid-po…
35
Year 1 of Dr. Yubin Zhou’s NIGMS R35 begins Sep 1: molecular control of calcium signaling at membrane contact sites, at the Institute of Biosciences and Technology in Houston. ibt.tamu.edu/stories/yubin-z…
3
405
IBT Stories is live 🎉 Discover research and people from the Institute of Biosciences and Technology at Texas A&M University—clear stories for a public audience. Start here: ibt.tamu.edu/stories/index.h… Questions or story ideas? [email protected]
1
61
New in Drug Discovery Today (May 2026): A statewide model that de-risks academic drug discovery Featuring IBT’s Peter Davies, Clifford Stephan & Margie Moczygemba 750+ projects • 60+ startups • 15 in clinic • ~$1B funding bit.ly/4nkq1Jw
🤖 Made with AI
Social media graphic for Drug Discovery Today article on Texas’s multi-institutional drug discovery model. Led by Suzanne Tomlinson-Mathis with IBT contributors Peter Davies, Clifford Stephan, and Margie Moczygemba. Impact: 750+ projects, 60+ startups, 15 in clinic, ~$1B funding.

ALT Social media graphic for Drug Discovery Today article on Texas’s multi-institutional drug discovery model. Led by Suzanne Tomlinson-Mathis with IBT contributors Peter Davies, Clifford Stephan, and Margie Moczygemba. Impact: 750+ projects, 60+ startups, 15 in clinic, ~$1B funding.

45
Texas A&M researcher Dr. Praveen Rajendran secures $1.32M from NCI PREVENT to study low-dose drug combinations targeting colitis-associated colorectal cancer, in collaboration with Drs. Dashwood (Texas A&M) & Vilar-Sanchez (MD Anderson). #CancerResearch #IBT
Dr. Rajendran profile photo.

ALT Dr. Rajendran profile photo.

Dr. Dashwood profile photo.

ALT Dr. Dashwood profile photo.

Dr. Vilar-Sanchez profile photo.

ALT Dr. Vilar-Sanchez profile photo.

1
93
Texas A&M Institute of Biosciences and Technology is proud to announce Dr. Jiang Chang as the 2025 Thomas Smith Memorial Lecturer by the American Heart Association. Established 1997 to honor Dr. Thomas Smith. Congrats, Dr. Chang! bit.ly/3JZ4V4u
Image of Dr. Chang

ALT Image of Dr. Chang

1
79
Texas A&M Institute of Biosciences and Technology is proud to announce Dr. Wenshe Liu as a 2025 Regents Professor Award Winner. The award honors professors for outstanding teaching, research, and service impacting institution, community, Texas, and beyond. Congrats, Dr. Liu!
Photo of Dr. Wenshe Liu

ALT Photo of Dr. Wenshe Liu

1
1
65
facultyaffairs.tamu.edu/elev…

University Awards

Faculty Affairs - Texas A&M University

facultyaffairs.tamu.edu
37
Load more